-
1
-
-
84893651437
-
Heart disease and stroke statistics-2014 update: a report from the American Heart Association
-
American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
-
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014;129:e28-e292.
-
(2014)
Circulation
, vol.129
, pp. e28-e292
-
-
Go, A.S.1
Mozaffarian, D.2
Roger, V.L.3
Benjamin, E.J.4
Berry, J.D.5
Blaha, M.J.6
-
2
-
-
70450081001
-
Major lipids, apolipoproteins, and risk of vascular disease
-
Di AE, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009;302:1993-2000.
-
(2009)
JAMA
, vol.302
, pp. 1993-2000
-
-
Di, A.E.1
Sarwar, N.2
Perry, P.3
Kaptoge, S.4
Ray, K.K.5
Thompson, A.6
-
4
-
-
33846365989
-
Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies
-
Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-414.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 403-414
-
-
Gami, A.S.1
Witt, B.J.2
Howard, D.E.3
Erwin, P.J.4
Gami, L.A.5
Somers, V.K.6
-
5
-
-
4444222221
-
Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults
-
Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-1250.
-
(2004)
Circulation
, vol.110
, pp. 1245-1250
-
-
Malik, S.1
Wong, N.D.2
Franklin, S.S.3
Kamath, T.V.4
L'Italien, G.J.5
Pio, J.R.6
-
8
-
-
50849096389
-
Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review
-
Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008;49:600-607.
-
(2008)
J Hepatol
, vol.49
, pp. 600-607
-
-
Sookoian, S.1
Pirola, C.J.2
-
9
-
-
80053219898
-
Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease
-
Sookoian S, Gianotti TF, Rosselli MS, Burgueno AL, Castano GO, Pirola CJ. Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. Atherosclerosis 2011;218:378-385.
-
(2011)
Atherosclerosis
, vol.218
, pp. 378-385
-
-
Sookoian, S.1
Gianotti, T.F.2
Rosselli, M.S.3
Burgueno, A.L.4
Castano, G.O.5
Pirola, C.J.6
-
10
-
-
34547673500
-
Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients
-
Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007;30:2119-2121.
-
(2007)
Diabetes Care
, vol.30
, pp. 2119-2121
-
-
Targher, G.1
Bertolini, L.2
Rodella, S.3
Tessari, R.4
Zenari, L.5
Lippi, G.6
-
11
-
-
77957375969
-
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease
-
Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341-1350.
-
(2010)
N Engl J Med
, vol.363
, pp. 1341-1350
-
-
Targher, G.1
Day, C.P.2
Bonora, E.3
-
12
-
-
84939650750
-
Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study
-
VanWagner LB, Wilcox JE, Colangelo LA, Lloyd-Jones DM, Carr JJ, Lima JA, et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology 2015;62:773-783.
-
(2015)
Hepatology
, vol.62
, pp. 773-783
-
-
VanWagner, L.B.1
Wilcox, J.E.2
Colangelo, L.A.3
Lloyd-Jones, D.M.4
Carr, J.J.5
Lima, J.A.6
-
13
-
-
84887058596
-
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
-
Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013;45:1353-1360.
-
(2013)
Nat Genet
, vol.45
, pp. 1353-1360
-
-
Beecham, A.H.1
Patsopoulos, N.A.2
Xifara, D.K.3
Davis, M.F.4
Kemppinen, A.5
Cotsapas, C.6
-
14
-
-
84871969762
-
Large-scale association analysis identifies new risk loci for coronary artery disease
-
Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013;45:25-33.
-
(2013)
Nat Genet
, vol.45
, pp. 25-33
-
-
Deloukas, P.1
Kanoni, S.2
Willenborg, C.3
Farrall, M.4
Assimes, T.L.5
Thompson, J.R.6
-
15
-
-
79953204259
-
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
-
Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011;43:333-338.
-
(2011)
Nat Genet
, vol.43
, pp. 333-338
-
-
Schunkert, H.1
Konig, I.R.2
Kathiresan, S.3
Reilly, M.P.4
Assimes, T.L.5
Holm, H.6
-
16
-
-
77955505564
-
Biological, clinical and population relevance of 95 loci for blood lipids
-
Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707-713.
-
(2010)
Nature
, vol.466
, pp. 707-713
-
-
Teslovich, T.M.1
Musunuru, K.2
Smith, A.V.3
Edmondson, A.C.4
Stylianou, I.M.5
Koseki, M.6
-
17
-
-
84898058547
-
Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk
-
Holmen OL, Zhang H, Fan Y, Hovelson DH, Schmidt EM, Zhou W, et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat Genet 2014;46:345-351.
-
(2014)
Nat Genet
, vol.46
, pp. 345-351
-
-
Holmen, O.L.1
Zhang, H.2
Fan, Y.3
Hovelson, D.H.4
Schmidt, E.M.5
Zhou, W.6
-
18
-
-
84887099827
-
Discovery and refinement of loci associated with lipid levels
-
Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet 2013;45:1274-1283.
-
(2013)
Nat Genet
, vol.45
, pp. 1274-1283
-
-
Willer, C.J.1
Schmidt, E.M.2
Sengupta, S.3
Peloso, G.M.4
Gustafsson, S.5
Kanoni, S.6
-
19
-
-
84898058711
-
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
-
Kozlitina J, Smagris E, Stender S, Nordestgaard BG, Zhou HH, Tybjaerg-Hansen A, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2014;46:352-356.
-
(2014)
Nat Genet
, vol.46
, pp. 352-356
-
-
Kozlitina, J.1
Smagris, E.2
Stender, S.3
Nordestgaard, B.G.4
Zhou, H.H.5
Tybjaerg-Hansen, A.6
-
20
-
-
84921487729
-
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
-
Dongiovanni P, Petta S, Maglio C, Fracanzani AL, Pipitone R, Mozzi E, et al. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology 2015;61:506-514.
-
(2015)
Hepatology
, vol.61
, pp. 506-514
-
-
Dongiovanni, P.1
Petta, S.2
Maglio, C.3
Fracanzani, A.L.4
Pipitone, R.5
Mozzi, E.6
-
21
-
-
84921528716
-
Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity
-
Sookoian S, Castano GO, Scian R, Mallardi P, Fernandez GT, Burgueno AL, et al. Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity. Hepatology 2015;61:515-525.
-
(2015)
Hepatology
, vol.61
, pp. 515-525
-
-
Sookoian, S.1
Castano, G.O.2
Scian, R.3
Mallardi, P.4
Fernandez, G.T.5
Burgueno, A.L.6
-
22
-
-
84906322683
-
Prevalence of the TM6SF2 variant and non-alcoholic fatty liver disease in Chinese
-
Wong VW, Wong GL, Tse CH, Chan HL. Prevalence of the TM6SF2 variant and non-alcoholic fatty liver disease in Chinese. J Hepatol 2014;61:708-709.
-
(2014)
J Hepatol
, vol.61
, pp. 708-709
-
-
Wong, V.W.1
Wong, G.L.2
Tse, C.H.3
Chan, H.L.4
-
23
-
-
84923064699
-
Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2
-
Zhou Y, Llaurado G, Oresic M, Hyotylainen T, Orho-Melander M, Yki-Jarvinen H. Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2. J Hepatol 2015;62:657-663.
-
(2015)
J Hepatol
, vol.62
, pp. 657-663
-
-
Zhou, Y.1
Llaurado, G.2
Oresic, M.3
Hyotylainen, T.4
Orho-Melander, M.5
Yki-Jarvinen, H.6
-
24
-
-
84903708160
-
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
-
Liu YL, Reeves HL, Burt AD, Tiniakos D, McPherson S, Leathart JB, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat Commun 2014;5:4309.
-
(2014)
Nat Commun
, vol.5
, pp. 4309
-
-
Liu, Y.L.1
Reeves, H.L.2
Burt, A.D.3
Tiniakos, D.4
McPherson, S.5
Leathart, J.B.6
-
25
-
-
84929607311
-
The TM6SF2 rs58542926 T Allele is significantly associated with nonalcoholic fatty liver disease in Chinese
-
Wang X, Liu Z, Peng Z, Liu W. The TM6SF2 rs58542926 T Allele is significantly associated with nonalcoholic fatty liver disease in Chinese. J Hepatol 2015;62:1438-1439.
-
(2015)
J Hepatol
, vol.62
, pp. 1438-1439
-
-
Wang, X.1
Liu, Z.2
Peng, Z.3
Liu, W.4
-
26
-
-
84902602986
-
TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content
-
Mahdessian H, Taxiarchis A, Popov S, Silveira A, Franco-Cereceda A, Hamsten A, et al. TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content. Proc Natl Acad Sci U S A 2014;111:8913-8918.
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, pp. 8913-8918
-
-
Mahdessian, H.1
Taxiarchis, A.2
Popov, S.3
Silveira, A.4
Franco-Cereceda, A.5
Hamsten, A.6
-
27
-
-
0038290163
-
Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology
-
Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 2003;56:297-303.
-
(2003)
J Clin Epidemiol
, vol.56
, pp. 297-303
-
-
Attia, J.1
Thakkinstian, A.2
D'Este, C.3
-
28
-
-
84960461431
-
TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children
-
Apr 20. [Epub ahead of print]
-
Grandone A, Cozzolino D, Marzuillo P, Cirillo G, Di Sessa A, Ruggiero L, et al. TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children. Pediatr Obes 2015 Apr 20. doi: 10.1111/ijpo.12032. [Epub ahead of print]
-
(2015)
Pediatr Obes
-
-
Grandone, A.1
Cozzolino, D.2
Marzuillo, P.3
Cirillo, G.4
Di Sessa, A.5
Ruggiero, L.6
-
29
-
-
84929347096
-
Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant
-
Mancina MR, Matikainen N, Maglio C, Soderlund S, Lundbom N, Hakkarainen A, et al. Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant. J Clin Endocrinol Metab 2015;100:E821-E825.
-
(2015)
J Clin Endocrinol Metab
, vol.100
, pp. E821-E825
-
-
Mancina, M.R.1
Matikainen, N.2
Maglio, C.3
Soderlund, S.4
Lundbom, N.5
Hakkarainen, A.6
-
30
-
-
79957462315
-
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
-
Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011;53:1883-1894.
-
(2011)
Hepatology
, vol.53
, pp. 1883-1894
-
-
Sookoian, S.1
Pirola, C.J.2
-
31
-
-
41049087605
-
Heterogeneity in meta-analyses of genome-wide association investigations
-
Ioannidis JP, Patsopoulos NA, Evangelou E. Heterogeneity in meta-analyses of genome-wide association investigations. PLoS One 2007;2:e841.
-
(2007)
PLoS One
, vol.2
, pp. e841
-
-
Ioannidis, J.P.1
Patsopoulos, N.A.2
Evangelou, E.3
-
33
-
-
81055145433
-
Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants
-
Park JH, Gail MH, Weinberg CR, Carroll RJ, Chung CC, Wang Z, et al. Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. Proc Natl Acad Sci U S A 2011;108:18026-18031.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 18026-18031
-
-
Park, J.H.1
Gail, M.H.2
Weinberg, C.R.3
Carroll, R.J.4
Chung, C.C.5
Wang, Z.6
-
34
-
-
26444571758
-
An evolutionary framework for common diseases: the ancestral-susceptibility model
-
Di RA, Hudson RR. An evolutionary framework for common diseases: the ancestral-susceptibility model. Trends Genet 2005;21:596-601.
-
(2005)
Trends Genet
, vol.21
, pp. 596-601
-
-
Di, R.A.1
Hudson, R.R.2
-
35
-
-
84907140876
-
Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia
-
Fouchier SW, Dallinga-Thie GM, Meijers JC, Zelcer N, Kastelein JJ, Defesche JC, et al. Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia. Circ Res 2014;115:552-555.
-
(2014)
Circ Res
, vol.115
, pp. 552-555
-
-
Fouchier, S.W.1
Dallinga-Thie, G.M.2
Meijers, J.C.3
Zelcer, N.4
Kastelein, J.J.5
Defesche, J.C.6
-
37
-
-
9044230921
-
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia
-
Bakker-Arkema RG, Davidson MH, Goldstein RJ, Davignon J, Isaacsohn JL, Weiss SR, et al. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA 1996;275:128-133.
-
(1996)
JAMA
, vol.275
, pp. 128-133
-
-
Bakker-Arkema, R.G.1
Davidson, M.H.2
Goldstein, R.J.3
Davignon, J.4
Isaacsohn, J.L.5
Weiss, S.R.6
-
38
-
-
84924420487
-
Mendelian randomization of blood lipids for coronary heart disease
-
Holmes MV, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, Nelson CP, et al. Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J 2015;36:539-550.
-
(2015)
Eur Heart J
, vol.36
, pp. 539-550
-
-
Holmes, M.V.1
Asselbergs, F.W.2
Palmer, T.M.3
Drenos, F.4
Lanktree, M.B.5
Nelson, C.P.6
-
39
-
-
79953745343
-
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits
-
Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011;7:e1001324.
-
(2011)
PLoS Genet
, vol.7
, pp. e1001324
-
-
Speliotes, E.K.1
Yerges-Armstrong, L.M.2
Wu, J.3
Hernaez, R.4
Kim, L.J.5
Palmer, C.D.6
-
40
-
-
84881232944
-
Cardiovascular and systemic risk in nonalcoholic fatty liver disease-atherosclerosis as a major player in the natural course of NAFLD
-
Lonardo A, Sookoian S, Chonchol M, Loria P, Targher G. Cardiovascular and systemic risk in nonalcoholic fatty liver disease-atherosclerosis as a major player in the natural course of NAFLD. Curr Pharm Des 2013;19:5177-5192.
-
(2013)
Curr Pharm Des
, vol.19
, pp. 5177-5192
-
-
Lonardo, A.1
Sookoian, S.2
Chonchol, M.3
Loria, P.4
Targher, G.5
-
41
-
-
77950017450
-
Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease
-
Sookoian S, Castano GO, Burgueno AL, Rosselli MS, Gianotti TF, Mallardi P, et al. Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease. Atherosclerosis 2010;209:585-591.
-
(2010)
Atherosclerosis
, vol.209
, pp. 585-591
-
-
Sookoian, S.1
Castano, G.O.2
Burgueno, A.L.3
Rosselli, M.S.4
Gianotti, T.F.5
Mallardi, P.6
-
42
-
-
78651353592
-
Disease-associated alleles in genome-wide association studies are enriched for derived low frequency alleles relative to HapMap and neutral expectations
-
Lachance J. Disease-associated alleles in genome-wide association studies are enriched for derived low frequency alleles relative to HapMap and neutral expectations. BMC Med Genomics 2010;3:57.
-
(2010)
BMC Med Genomics
, vol.3
, pp. 57
-
-
Lachance, J.1
|